Nanoviricides NNVC
NYSE NNVC
$1.52 +0.01 (+0.66%)
As of: Oct 22, 2026 · 9:59 AM EDT

Nanoviricides (NNVC) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Nanoviricides (NNVC) recorded Depreciation & Amortization (CF) of $127,682 in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 19.7% from $159,059 a year earlier but up 0.1% from the prior quarter.

Analysis

Nanoviricides (NNVC) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Nanoviricides reported Depreciation & Amortization (CF) of $517,016, down 29.7% from FY2025.

  • Annual Depreciation & Amortization (CF) has a five-year compound annual growth rate of -5.8% (FY2021 to FY2026).
  • Across earlier fiscal years, Depreciation & Amortization (CF) came in at $735,536 in FY2025 (-2.0%), $750,744 in FY2024 (+1.6%), $739,259 in FY2023 (+3.4%) and $715,055 in FY2022 (+2.7%).
  • Quarterly Depreciation & Amortization (CF) has ranged from $127,566 in fiscal Q3 2026 to $193,816 in fiscal Q2 2025 over the past five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined for five consecutive quarters, with an average decline of 15.6% over the last eight quarters.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 6.8% in fiscal Q4 2022, against a decline of 32.5% in fiscal Q3 2026 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $127,566 (Q3 2026), $131,016 (Q2 2026) and $130,752 (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,157.52 Bn 1,126.11 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 631.39 Bn 549.92 Bn 17.26 Bn 1.96 Bn
3 AbbVie 498.93 Bn 472.04 Bn 12.70 Bn 194.00 Mn
4 Merck 376.05 Bn 330.42 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 301.98 Bn 265.97 Bn 11.24 Bn -
6 Astrazeneca 265.05 Bn 238.74 Bn 12.86 Bn 1.93 Bn
7 Amgen 240.27 Bn 195.67 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 193.08 Bn 167.27 Bn 6.22 Bn 98.00 Mn
9 Pfizer 171.85 Bn 118.50 Bn 10.94 Bn 1.62 Bn
10 Nanoviricides 30.69 Mn 18.35 Mn - 127,682.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 127,682.00
Mar 31, 2026 127,566.00
Dec 31, 2025 131,016.00
Sep 30, 2025 130,752.00
Jun 30, 2025 159,059.00
Mar 31, 2025 189,114.00
Dec 31, 2024 193,816.00
Sep 30, 2024 193,546.00
Jun 30, 2024 188,535.00
Mar 31, 2024 187,889.00
Dec 31, 2023 187,262.00
Sep 30, 2023 187,057.00
Jun 30, 2023 186,814.00
Mar 31, 2023 186,255.00
Dec 31, 2022 184,855.00
Sep 30, 2022 181,335.00
Jun 30, 2022 185,888.00
Mar 31, 2022 179,492.00
Dec 31, 2021 175,318.00
Sep 30, 2021 174,357.00
API Access

Nanoviricides Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NNVC&period=max&api_key=YOUR_API_KEY